Research output per year
Research output per year
Personal profile
Fields of Science
- 3111 Biomedicine
International and National Collaboration
Publications and projects within past five years.
-
Antibiotic treatment using amoxicillin-clavulanic acid impairs gut mycobiota development through modification of the bacterial ecosystem
Spatz, M., Da Costa, G., Ventin-Holmberg, R., Planchais, J., Michaudel, C., Wang, Y., Danne, C., Lapiere, A., Michel, M-L., Kolho, K-L., Langella, P., Sokol, H. & Richard, M. L., 10 Apr 2023, In: Microbiome. 11, 1, 18 p., 73.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Mikrobilääkkeet aiheuttavat epätasapainoa imeväisten suoliston sienimikrobistossa
Ventin-Holmberg, R., Saqib, S., Korpela, K., Nikkonen, A., Peltola, V., Salonen, A., de Vos, W. M. & Kolho, K-L., 2022, In: Duodecim. 138, 11, p. 1045 1 p.Research output: Contribution to journal › Comment/debate › Professional
Open AccessFile -
The Effect of Antibiotics on the Infant Gut Fungal Microbiota
Ventin-Holmberg, R., Saqib, S., Korpela, K., Nikkonen, A., Peltola, V., Salonen, A., de Vos, W. M. & Kolho, K-L., Apr 2022, In: Journal of fungi . 8, 4, 11 p., 328.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
The gut fungal and bacterial microbiota in pediatric patients with inflammatory bowel disease introduced to treatment with anti-tumor necrosis factor-α
Ventin-Holmberg, R., Höyhtyä, M., Saqib, S., Korpela, K., Nikkonen, A., Salonen, A., de Vos, W. M. & Kolho, K. L., 22 Apr 2022, In: Scientific Reports. 12, 1, 11 p., 6654.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Bacterial and Fungal Profiles as Markers of Infliximab Drug Response in Inflammatory Bowel Disease
Ventin-Holmberg, R., Eberl, A., Saqib, S., Korpela, K., Virtanen, S., Salonen, A., Sipponen, T. M., Saavalainen, P. & Nissilä, E., 22 Jun 2021, In: Journal of Crohn's and Colitis. 15, 6, p. 1019-1031 13 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile
Press/Media
-
Suolistomikrobien tunnistaminen vähentäisi turhia IBD:n lääkityksiä – ”Tutkimuksemme perusteella lääke ei tehoa joka kolmannelle potilaalle”
Eija Nissilä & Rebecka Ventin-Holmberg
15/02/2021
1 item of Media coverage
Press/Media: Press / Media